Sunday, November 18, 2018
News

Lupin receives FDA approval for generic Nitrofurantoin Capsules USP

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Mumbai | Thursday, Jul 12 2018 IST
Pharma Major, Lupin said that it has received final approval for its Nitrofurantoin Capsules USP (Macrocrystals),50 mg and 100 mg from the United States Food and Drug Administration(FDA) to market a generic version of Alvogen Malta Operations Ltd.'s Macrodantin Capsules, 50 mg and 100 mg.

Lupin's Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg is the generic version of Alvogen Malta Operations Ltd.'s Macrodantin Capsules, 50 mg and 100 mg, company said in a filing with BSE. It is specifically indicated for the treatment of urinary tract infections (UTI) when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species.

Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg had annual sales of approximately USD 27 million in the US (IQVIA MAT April 2018).

UNI JS SM SY 1446

-- (UNI) -- C-1-DL0171-1435614.Xml

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
6 dead in truck-car collision...
Rahul challenges PM Modi for debate over...
Nagapattinam: Residents bear brunt of cy...
Ajay Bhushan Pandey appointed new revenu...
Sex education before college lowers risk...
INLD's Adhikar Yatra from Dec 1 for SYL ...
More...    
 
 Top Stories
Trump administration denies reachin... 
'18 Syrian troops killed in attack ... 
Nepal: 3 educational institutions s... 
Motherhood has changed Cheryl Tweed... 
Argentine govt admits it lacks mean... 
6 dead in truck-car collision... 
Nagapattinam: Residents bear brunt ... 
US-China issues take center stage a...